These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 11816705
1. Factor V Leiden and factor V R2 allele: high-throughput analysis and association with venous thromboembolism. Benson JM, Ellingsen D, El-Jamil M, Jenkins M, Miller CH, Dilley A, Evatt BL, Hooper WC. Thromb Haemost; 2001 Nov; 86(5):1188-92. PubMed ID: 11816705 [Abstract] [Full Text] [Related]
2. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms. Bouaziz-Borgi L, Nguyen P, Hezard N, Musharrafieh U, Almawi WY, Mahjoub T. Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744 [Abstract] [Full Text] [Related]
3. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon. Bouaziz-Borgi L, Almawi WY, Mtiraoui N, Nsiri B, Keleshian SH, Kreidy R, Louzir B, Hezard N, Mahjoub T. Am J Hematol; 2006 Aug; 81(8):641-3. PubMed ID: 16823828 [Abstract] [Full Text] [Related]
7. Easy, accurate and reliable screening for SNPs by ion pair/reverse phase HPLC: simultaneous detection of factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T variants. Neitzel B, Matern C, Holinski-Feder E. Clin Lab; 2003 Aug; 49(7-8):313-8. PubMed ID: 12908731 [Abstract] [Full Text] [Related]
8. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C. Luddington R, Jackson A, Pannerselvam S, Brown K, Baglin T. Thromb Haemost; 2000 Feb; 83(2):204-8. PubMed ID: 10739373 [Abstract] [Full Text] [Related]
12. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium. Dindagur N, Kruthika-Vinod TP, Christopher R. Thromb Res; 2007 Feb; 119(4):497-500. PubMed ID: 16781765 [Abstract] [Full Text] [Related]
13. Allele-specific PCR amplification of factor V Leiden to identify patients at risk for thromboembolism. Blasczyk R, Wehling J, Ritter M, Neubauer A, Riess H. Beitr Infusionsther Transfusionsmed; 1997 Feb; 34():236-41. PubMed ID: 9356679 [Abstract] [Full Text] [Related]
14. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis. Kostka H, Schwarz T, Schellong S, Mix C, Kuhlisch E, Temelkova-Kurktschiev T, Henkel E, Köhler C, Gehrisch S, Siegert G. Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728 [Abstract] [Full Text] [Related]
17. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages. Mahjoub T, Mtiraoui N, Tamim H, Hizem S, Finan RR, Nsiri B, Almawi WY. Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341 [Abstract] [Full Text] [Related]